JPS61126028A - コロニ−形成刺激因子産生ヒト由来細胞株 - Google Patents
コロニ−形成刺激因子産生ヒト由来細胞株Info
- Publication number
- JPS61126028A JPS61126028A JP59248201A JP24820184A JPS61126028A JP S61126028 A JPS61126028 A JP S61126028A JP 59248201 A JP59248201 A JP 59248201A JP 24820184 A JP24820184 A JP 24820184A JP S61126028 A JPS61126028 A JP S61126028A
- Authority
- JP
- Japan
- Prior art keywords
- cell
- cells
- subculture
- human
- tlc
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 102000007644 Colony-Stimulating Factors Human genes 0.000 title abstract 2
- 108010071942 Colony-Stimulating Factors Proteins 0.000 title abstract 2
- 210000004027 cell Anatomy 0.000 claims abstract description 73
- 239000002609 medium Substances 0.000 claims abstract description 28
- 210000001519 tissue Anatomy 0.000 claims abstract description 10
- 230000004663 cell proliferation Effects 0.000 claims abstract description 8
- 210000000349 chromosome Anatomy 0.000 claims abstract description 7
- 239000012980 RPMI-1640 medium Substances 0.000 claims abstract description 4
- 108091003079 Bovine Serum Albumin Proteins 0.000 claims description 11
- 239000012091 fetal bovine serum Substances 0.000 claims description 11
- 230000005757 colony formation Effects 0.000 claims description 7
- 238000004519 manufacturing process Methods 0.000 claims description 7
- 206010058467 Lung neoplasm malignant Diseases 0.000 claims description 5
- 201000005202 lung cancer Diseases 0.000 claims description 5
- 208000020816 lung neoplasm Diseases 0.000 claims description 5
- 210000005260 human cell Anatomy 0.000 claims description 2
- 230000004936 stimulating effect Effects 0.000 claims description 2
- 108090000790 Enzymes Proteins 0.000 abstract description 6
- 102000004190 Enzymes Human genes 0.000 abstract description 6
- 210000002966 serum Anatomy 0.000 abstract description 6
- 229920006395 saturated elastomer Polymers 0.000 abstract description 5
- 206010028980 Neoplasm Diseases 0.000 abstract description 4
- 230000035755 proliferation Effects 0.000 abstract description 4
- 239000006185 dispersion Substances 0.000 abstract description 2
- 210000003714 granulocyte Anatomy 0.000 abstract description 2
- 210000000265 leukocyte Anatomy 0.000 abstract description 2
- 241000283690 Bos taurus Species 0.000 abstract 1
- 201000009030 Carcinoma Diseases 0.000 abstract 1
- 230000001747 exhibiting effect Effects 0.000 abstract 1
- 210000003754 fetus Anatomy 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 14
- 239000000243 solution Substances 0.000 description 11
- 239000003656 tris buffered saline Substances 0.000 description 7
- 238000000034 method Methods 0.000 description 6
- 229940088598 enzyme Drugs 0.000 description 5
- 238000003556 assay Methods 0.000 description 4
- 238000012258 culturing Methods 0.000 description 4
- 210000004700 fetal blood Anatomy 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 239000002953 phosphate buffered saline Substances 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 210000001185 bone marrow Anatomy 0.000 description 3
- 210000002798 bone marrow cell Anatomy 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- 229920000609 methyl cellulose Polymers 0.000 description 3
- 239000001923 methylcellulose Substances 0.000 description 3
- 239000004033 plastic Substances 0.000 description 3
- 239000006285 cell suspension Substances 0.000 description 2
- 239000000032 diagnostic agent Substances 0.000 description 2
- 229940039227 diagnostic agent Drugs 0.000 description 2
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 2
- 239000010410 layer Substances 0.000 description 2
- 201000002364 leukopenia Diseases 0.000 description 2
- 231100001022 leukopenia Toxicity 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 239000012086 standard solution Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 229940124597 therapeutic agent Drugs 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 101100234244 Arabidopsis thaliana KDTA gene Proteins 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 102000029816 Collagenase Human genes 0.000 description 1
- 108060005980 Collagenase Proteins 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 101000746373 Homo sapiens Granulocyte-macrophage colony-stimulating factor Proteins 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 229920001944 Plastisol Polymers 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000001464 adherent effect Effects 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 239000012888 bovine serum Substances 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 210000003850 cellular structure Anatomy 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000013330 chicken meat Nutrition 0.000 description 1
- 229960002424 collagenase Drugs 0.000 description 1
- 239000012228 culture supernatant Substances 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- -1 disodium salt Chemical class 0.000 description 1
- 108010007093 dispase Proteins 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- YMTINGFKWWXKFG-UHFFFAOYSA-N fenofibrate Chemical compound C1=CC(OC(C)(C)C(=O)OC(C)C)=CC=C1C(=O)C1=CC=C(Cl)C=C1 YMTINGFKWWXKFG-UHFFFAOYSA-N 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229960004712 metrizoic acid Drugs 0.000 description 1
- 210000005087 mononuclear cell Anatomy 0.000 description 1
- 230000001459 mortal effect Effects 0.000 description 1
- 210000003643 myeloid progenitor cell Anatomy 0.000 description 1
- 239000008177 pharmaceutical agent Substances 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 210000002706 plastid Anatomy 0.000 description 1
- 239000004999 plastisol Substances 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 238000009941 weaving Methods 0.000 description 1
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP59248201A JPS61126028A (ja) | 1984-11-26 | 1984-11-26 | コロニ−形成刺激因子産生ヒト由来細胞株 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP59248201A JPS61126028A (ja) | 1984-11-26 | 1984-11-26 | コロニ−形成刺激因子産生ヒト由来細胞株 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS61126028A true JPS61126028A (ja) | 1986-06-13 |
| JPS6314946B2 JPS6314946B2 (enrdf_load_stackoverflow) | 1988-04-02 |
Family
ID=17174697
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP59248201A Granted JPS61126028A (ja) | 1984-11-26 | 1984-11-26 | コロニ−形成刺激因子産生ヒト由来細胞株 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS61126028A (enrdf_load_stackoverflow) |
-
1984
- 1984-11-26 JP JP59248201A patent/JPS61126028A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS6314946B2 (enrdf_load_stackoverflow) | 1988-04-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5965436A (en) | Method of isolating mesenchymal stem cells associated with isolated megakaryocytes by isolating megakaryocytes | |
| US4423145A (en) | Enhanced growth medium and method for culturing human mammary epithelial cells | |
| US20160206780A1 (en) | Matrix Scaffold for Three-Dimensional Cell Cultivation, Methods of Construction Thereof and Uses Thereof | |
| KR102426746B1 (ko) | 모낭 줄기 세포의 3d 오가노이드 시스템을 이용하여 모발을 재생시키기 위한 방법 및 시스템 | |
| WO2007024441A2 (en) | Compositions of cells enriched for combinations of various stem and progenitor cell populations, methods of use thereof and methods of private banking thereof | |
| KR101293364B1 (ko) | 조직공학적 인간 각막 내피의 재건 방법 | |
| JPH02109976A (ja) | Ｌａｋ活性リンパ細胞の調製法 | |
| Sato et al. | Development of capillary networks from rat microvascular fragments in vitro: the role of myofibroblastic cells | |
| CN102876630A (zh) | 一种高效分离和扩增人脐带血间充质干细胞的方法 | |
| US6093393A (en) | Methods for preparing and using clonogenic fibroblasts and transfected clonogenic fibroblasts | |
| RO106655B1 (ro) | Sistem tridimensional de cultura de tesuturi si celule | |
| IL277467B1 (en) | Method for producing natural killer cells | |
| KR102565022B1 (ko) | 제대 중간엽 줄기 세포 및 그의 세포 시트의 제조 방법 | |
| CN108865986A (zh) | 用于修复关节软骨损伤/缺损的间充质干细胞制剂及其制备方法和应用 | |
| US4100022A (en) | Process for preparing a curing agent for myelogenic leukemia | |
| CN112342190A (zh) | 一种提高间充质干细胞外泌体产量的方法及其应用 | |
| CN111518834A (zh) | Car-t细胞及其制备方法和药物 | |
| JPS62249926A (ja) | 試験管内骨髄複製方法 | |
| CN114209814A (zh) | Tnfsf15蛋白在促进骨髓干细胞分化为巨噬细胞并扩增中的用途 | |
| KR101202836B1 (ko) | 세포응집을 이용한 인간 혈액 유래 혈구 세포괴의 유도와 이를 이용한 혈중 성체줄기세포 및 전구세포의 증폭방법 및 상기의 방법에 의해 제조된 줄기세포 | |
| Vizcardo et al. | A three-dimensional thymic culture system to generate murine induced pluripotent stem cell-derived tumor antigen-specific thymic emigrants | |
| JPH10136978A (ja) | 造血幹細胞の培養方法 | |
| JPS61126028A (ja) | コロニ−形成刺激因子産生ヒト由来細胞株 | |
| KR102787753B1 (ko) | 인체 말초 혈액의 자연살해세포 보다 더 높은 수준의 NCR, 살상능 및 IFN-γ 생산능력을 갖는 유사기억 자연살해세포의 제조 방법 | |
| KR102736008B1 (ko) | 고순도 및 고효율의 자연살해세포 제조방법 및 이의 용도 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EXPY | Cancellation because of completion of term |